News Home

Is Evofem Biosciences Inc (EVFM) a Good Choice in Biotechnology Wednesday?

Wednesday, August 10, 2022 01:09 PM | InvestorsObserver Analysts
Is Evofem Biosciences Inc (EVFM) a Good Choice in Biotechnology Wednesday?

Evofem Biosciences Inc (EVFM) is near the middle in its industry group according to InvestorsObserver. EVFM gets an overall rating of 51. That means it scores higher than 51 percent of stocks. Evofem Biosciences Inc gets a 49 rank in the Biotechnology industry. Biotechnology is number 30 out of 148 industries.

Overall Score - 51
EVFM has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on EVFM!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Evofem Biosciences Inc Stock Today?

Evofem Biosciences Inc (EVFM) stock is lower by -12.77% while the S&P 500 is up 1.84% as of 1:08 PM on Wednesday, Aug 10. EVFM has fallen -$0.08 from the previous closing price of $0.62 on volume of 35,989,808 shares. Over the past year the S&P 500 has fallen -5.37% while EVFM has fallen -95.75%. EVFM lost -$18.97 per share the over the last 12 months. Click Here to get the full Stock Report for Evofem Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App